Literature DB >> 1359789

Multidrug resistance gene (P-glycoprotein) expression in the human fetus.

C K van Kalken1, G Giaccone, P van der Valk, C M Kuiper, M M Hadisaputro, S A Bosma, R J Scheper, C J Meijer, H M Pinedo.   

Abstract

P-glycoprotein, a transmembrane protein associated with multidrug resistance in cancer cells, is also expressed in normal tissues. To get more insight into the physiologic role of mdr1/P-glycoprotein, we investigated its expression in human fetal tissues after 7 to 38 weeks of gestation by an immunohistochemical technique, using three different monoclonal antibodies, and by a sensitive RNAse protection assay. Expression of mdr1-mRNA could already be demonstrated in the embryonal phase of human development, after 7 weeks of gestation. Comparing the adult with the fetal tissue distribution, differences were found in specific organs, such as adrenal, intestine, respiratory epithelium, and brain capillaries. In the fetal zone cells of the fetal adrenal cortex no staining was observed by immunohistochemistry, whereas the definitive zone showed increasing expression throughout gestation. Prenatal intestine did not show staining of the epithelium, although definite mdr1-mRNA expression was observed in late specimens. Interestingly, respiratory epithelium of main bronchi and pharynx, not expressing P-gp in adults, did stain positive. Expression of P-gp in brain capillaries was not observed before the third trimester of pregnancy, whereas in kidney and liver, mdr1-mRNA expression and staining for P-glycoprotein were detected in early fetal life (11 to 14 weeks). These findings suggest a pivotal role of P-glycoprotein in physiology of various organs already in early phases of human development and may help to identify its physiologic substrates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1359789      PMCID: PMC1886663     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

Review 1.  Multidrug resistance from the clinical point of view.

Authors:  C K van Kalken; H M Pinedo; G Giaccone
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

2.  Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies.

Authors:  N Kartner; D Evernden-Porelle; G Bradley; V Ling
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

3.  Expression of a multidrug-resistance gene in human tumors and tissues.

Authors:  A T Fojo; K Ueda; D J Slamon; D G Poplack; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

Review 4.  Regulation of the primate fetal adrenal cortex.

Authors:  G J Pepe; E D Albrecht
Journal:  Endocr Rev       Date:  1990-02       Impact factor: 19.871

5.  Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

Authors:  C Cordon-Cardo; J P O'Brien; D Casals; L Rittman-Grauer; J L Biedler; M R Melamed; J R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 6.  P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins.

Authors:  P F Juranka; R L Zastawny; V Ling
Journal:  FASEB J       Date:  1989-12       Impact factor: 5.191

7.  Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  J Histochem Cytochem       Date:  1989-02       Impact factor: 2.479

8.  3 beta-hydroxysteroid dehydrogenase/isomerase in the fetal zone and neocortex of the human fetal adrenal gland.

Authors:  K M Doody; B R Carr; W E Rainey; W Byrd; B A Murry; R C Strickler; J L Thomas; J I Mason
Journal:  Endocrinology       Date:  1990-05       Impact factor: 4.736

9.  Sex-dependent and independent expression of the P-glycoprotein isoforms in Chinese hamster.

Authors:  G Bradley; E Georges; V Ling
Journal:  J Cell Physiol       Date:  1990-12       Impact factor: 6.384

10.  Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance.

Authors:  R J Scheper; J W Bulte; J G Brakkee; J J Quak; E van der Schoot; A J Balm; C J Meijer; H J Broxterman; C M Kuiper; J Lankelma
Journal:  Int J Cancer       Date:  1988-09-15       Impact factor: 7.396

View more
  29 in total

Review 1.  Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.

Authors:  Hitoshi Ishimoto; Robert B Jaffe
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

Review 2.  Challenges Associated with Route of Administration in Neonatal Drug Delivery.

Authors:  Matthew W Linakis; Jessica K Roberts; Anita C Lala; Michael G Spigarelli; Natalie J Medlicott; David M Reith; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2016-02       Impact factor: 6.447

3.  Differential expression of ABC transporters (MDR1, MRP1, BCRP) in developing human embryos.

Authors:  A Konieczna; B Erdösová; R Lichnovská; M Jandl; K Cížková; J Ehrmann
Journal:  J Mol Histol       Date:  2011-10-20       Impact factor: 2.611

Review 4.  An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.

Authors:  Lyrialle W Han; Chunying Gao; Qingcheng Mao
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-08-03       Impact factor: 4.481

5.  MDR1 up-regulated by apoptotic stimuli suppresses apoptotic signaling.

Authors:  Toshiyuki Sakaeda; Tsutomu Nakamura; Midori Hirai; Takashi Kimura; Atsushi Wada; Tatsurou Yagami; Hironao Kobayashi; Shunji Nagata; Noboru Okamura; Takayoshi Yoshikawa; Toshiro Shirakawa; Akinobu Gotoh; Masafumi Matsuo; Katsuhiko Okumura
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

Review 6.  Creating a continuum of care: integrating obstetricians and gynecologists in the care of young cancer patients.

Authors:  Betty Y Kong; Robin M Skory; Teresa K Woodruff
Journal:  Clin Obstet Gynecol       Date:  2011-12       Impact factor: 2.190

Review 7.  Developmental pharmacokinetics in pediatric populations.

Authors:  Hong Lu; Sara Rosenbaum
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

Review 8.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

9.  P-glycoprotein is expressed in the mineralizing regions of the skeleton.

Authors:  D C Mangham; A Cannon; S Komiya; R L Gendron; K Dunussi; M C Gebhardt; H J Mankin; R J Arceci
Journal:  Calcif Tissue Int       Date:  1996-03       Impact factor: 4.333

10.  Developmental trajectory of intestinal MDR1/ABCB1 mRNA expression in children.

Authors:  Tomoyuki Mizuno; Tsuyoshi Fukuda; Satohiro Masuda; Shinji Uemoto; Kazuo Matsubara; Ken-Ichi Inui; Alexander A Vinks
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.